Gregory P Geba

5PUBLICATIONS
9CO-AUTHORS
Foetal development and medicineEnvironment and culturePredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Pain
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 09, 2024
Assessing the safety and pharmacokinetics of casirivimab and imdevimab (CAS+IMD) in a cohort of pregnant outpatients with COVID-19: results from an adaptive, multicentre, randomised, double-blind, phase 1/2/3 study.

Thomas D Norton, Mazhar Thakur, Samit Ganguly

|Jan 17, 2024
Thematic analysis to explore patients' experiences with long COVID-19: a conceptual model of symptoms and impacts on daily lives.

Diana Rofail, Selin Somersan-Karakaya, Julia Y Choi

|Jul 17, 2023
Effect of proprotein convertase subtilisin/kexin type 9 inhibition on cancer events: A pooled, post hoc, competing risk analysis of alirocumab clinical trials.

Kusha A Mohammadi, Taylor Brackin, Gregory G Schwartz

|Jul 02, 2021
Successful Clearance of 300 Day SARS-CoV-2 Infection in a Subject with B-Cell Depletion Associated Prolonged (B-DEAP) COVID by REGEN-COV Anti-Spike Monoclonal Antibody Cocktail.

Arnaud C Drouin, Marc W Theberge, Sharon Y Liu

|Nov 17, 2020
Efficacy and safety of fasinumab in patients with chronic low back pain: a phase II/III randomised clinical trial.

Paula Dakin, Alan J Kivitz, Joseph S Gimbel

Pageof 1

Frequent Collaborators

1 joint publications

Paula Dakin

1 joint publications

Joseph S Gimbel

1 joint publications

Nebojsa Skrepnik

1 joint publications

David M Weinreich